Prognostic Features in Intermediate-Size Supraglottic Tumors Treated With Open Supraglottic Laryngectomy.
Supraglottic carcinoma
adverse pathological features
open partial horizontal laryngectomy type I
supraglottic laryngectomy
tumor size
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
09
12
2020
received:
06
11
2020
accepted:
23
12
2020
pubmed:
6
1
2021
medline:
4
6
2021
entrez:
5
1
2021
Statut:
ppublish
Résumé
We investigated growth patterns and pathological features in intermediate-size laryngeal carcinoma amenable to supraglottic laryngectomy. Retrospective cohort study. We reviewed patients who underwent an open partial horizontal laryngectomy (OPHL) type I. We analyzed pathological data, tumor sizes, overall survival, disease-specific survival, local control, and laryngeal preservation. Results were stratified between three groups: group I comprised patients with endolaryngeal carcinoma, group II comprised patients with anterior epilaryngeal carcinoma who underwent an OPHL type I + base of tongue (BOT), group III comprised patients with lateral epilaryngeal carcinoma who underwent an OPHL type I + pyriform sinus (PIR). Sixty-eight patients were analyzed. The 5-year rates of overall survival, disease-specific survival, local control, and laryngeal preservation were 68.4%, 83.7%, 91.6%, and 98.3%, respectively. The tumor sizes at pathological examination were similar between the three groups (mean 27 mm, P = .80) and were associated with pathological features, notably pre-epiglottic space (PES) invasion (24.9 mm vs. 32.2 mm, P = .01), occult invaded lymph nodes (22.6 mm vs. 29.9 mm, P = .03), and trends for margins status (26.5 mm vs. 29.3 mm, P = .45). The risks of PES invasion, occult lymph nodes, and positive margins, respectively, predominated in group I (41.7%), group II (56.3%), and group III (23.3%). In intermediate-size tumors amenable to supraglottic laryngectomy, pathological features are associated with tumor size according to group stratification based on tumor location. 4 Laryngoscope, 131:E1980-E1986, 2021.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E1980-E1986Informations de copyright
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
Surveillance E, and End Results (SEER) Cancer Statistics Review (CSR), 1975-2017, U. S. National Institute of Health, National Cancer Institute. Relative Survival by Year of Diagnosis, Both Sexes. https://seer.cancer.gov/csr/1975_2017/results_single/sect_12_table.10.pdf. Accessed December 1, 2020.
Cabanillas R, Rodrigo JP, Llorente JL, Suarez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 2008;30:750-755.
Razafindranaly V, Lallemant B, Aubry K, et al. Clinical outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma: experience of a French evaluation cooperative subgroup of GETTEC. Head Neck 2016;38:E1097-E1101.
Lechien JR, Fakhry N, Saussez S, et al. Surgical, clinical and functional outcomes of transoral robotic surgery for supraglottic laryngeal cancers: a systematic review. Oral Oncol 2020;109:104848.
Asik MB, Satar B, Serdar M. Meta-analytic comparison of robotic and transoral laser surgical procedures in supraglottic carcinoma. J Laryngol Otol 2019;133:404-412.
Park YM, Byeon HK, Chung HP, Choi EC, Kim SH. Comparison of treatment outcomes after transoral robotic surgery and supraglottic partial laryngectomy: our experience with seventeen and seventeen patients respectively. Clin Otolaryngol 2013;38:270-274.
Dombree M, Crott R, Lawson G, Janne P, Castiaux A, Krug B. Cost comparison of open approach, transoral laser microsurgery and transoral robotic surgery for partial and total laryngectomies. Eur Arch Otorhinolaryngol 2014;271:2825-2834.
Chiesa Estomba CM, Betances Reinoso FA, Lorenzo Lorenzo AI, Farina Conde JL, Araujo Nores J, Santidrian Hidalgo C. Functional outcomes of supraglottic squamous cell carcinoma treated by transoral laser microsurgery compared with horizontal supraglottic laryngectomy in patients younger and older than 65 years. Acta Otorhinolaryngol Ital 2016;36:450-458.
Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 2009;266:1333-1352.
Gorphe P. A contemporary review of evidence for transoral robotic surgery in laryngeal cancer. Front Oncol 2018;8:121.
Succo G, Peretti G, Piazza C, et al. Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society. Eur Arch Otorhinolaryngol 2014;271:2489-2496.
Succo G, Crosetti E. Limitations and opportunities in open laryngeal organ preservation surgery: current role of OPHLs. Front Oncol 2019;9:408.
Zhou J, Zhou L, Tao L, et al. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients. Acta Otolaryngol 2018;138:1028-1034.
Pedregal-Mallo D, Sanchez Canteli M, Lopez F, Alvarez-Marcos C, Llorente JL, Rodrigo JP. Oncological and functional outcomes of transoral laser surgery for laryngeal carcinoma. Eur Arch Otorhinolaryngol 2018;275:2071-2077.
van der Woerd B, Patel KB, Nichols AC, Fung K, Yoo J, MacNeil SD. Functional outcomes in early (T1/T2) supraglottic cancer: a systematic review. J Otolaryngol Head Neck Surg 2018;47:76.
Bocca E, Pignataro O, Oldini C. Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol 1983;92:14-18.
Lee NK, Goepfert H, Wendt CD. Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer Center experience with combined therapy. Laryngoscope 1990;100:831-836.
Bron LP, Soldati D, Monod ML, et al. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma. Eur Arch Otorhinolaryngol 2005;262:302-306.
Vilaseca I, Bernal-Sprekelsen M, Luis Blanch J. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors. Head Neck 2010;32:929-938.
Hinni ML, Salassa JR, Grant DG, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007;133:1198-1204.
Vilaseca I, Blanch JL, Berenguer J, et al. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: sixteen years of experience. Head Neck 2016;38:1050-1057.
Bertolin A, Lionello M, Russo S, Rizzotto G, Lucioni M. Could laser-assisted dissection of the pre-epiglottic space affect functional outcome after ESL? Laryngoscope 2018;128:1371-1378.
Ogura JH, Marks JE, Freeman RB. Results of conservation surgery for cancers of the supraglottis and pyriform sinus. Laryngoscope 1980;90:591-600.
Tassone P, Savard C, Topf MC, et al. Association of positive initial margins with survival among patients with squamous cell carcinoma treated with total laryngectomy. JAMA Otolaryngol Head Neck Surg 2018;144:1030-1036.